The liposomal chemotherapy drug market size was valued at USD 3.69 billion in 2025 and is expected to reach USD 7.13 billion by 2033, at a CAGR of 8.60% during the forecast period
The market growth is primarily driven by the increasing prevalence of cancer worldwide and the growing preference for advanced drug-delivery systems that enhance therapeutic efficacy while reducing systemic toxicity
3 Views